Drug General Information
Drug ID
D0S0BJ
Former ID
DIB013862
Drug Name
IMCgp100
Drug Type
Monoclonal antibody
Indication Melanoma [ICD9: 172; ICD10:C43] Phase 2 [889433]
Company
Immunocore
Target and Pathway
Target(s) Melanocytes lineage-specific antigen GP100 Target Info Modulator
References
Ref 889433ClinicalTrials.gov (NCT03070392) Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma